Alcohol Use Disorder (AUD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

Alcohol Use Disorder (AUD) Marketed and Pipeline Drugs Report Overview

Alcohol use disorder (AUD) is an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences. AUD encompasses the conditions that some people refer to as alcohol abuse, alcohol dependence, alcohol addiction, and the colloquial term, alcoholism. The pathogenesis of AUD is not fully known, however, several factors contribute to its development, such as biological, environmental, social, psychological, and genetic factors. The level of cognitive functioning, and certain existing personality disorders also contribute to its development.

The Alcohol Use Disorder (AUD) marketed and pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, and pricing and reimbursement of therapy in major countries. Furthermore, the report analyzes late-to-mid-stage pipeline products with Phase Transition Success Rate (PTSR) and Likelihood of Approval (LoA) for AUD.

The report also provides actionable insights into the clinical and commercial landscapes of AUD drugs, M&A deals, and market catalysts. These critical data will help you develop and design your in-licensing and out-licensing strategies. Furthermore, identify companies with the most robust pipelines to create smart business goals.

AUD Marketed Drugs Segmentation by Mechanisms of Action

In 2023, among the marketed AUD drugs available, most of the drugs are receptor agonists by mechanism of action. Other mechanisms of action followed by the AUD marketed drugs are receptor antagonist, enzyme inhibitor, ion channel blocker, and transporter inhibitor, among others.

AUD Marketed Drugs Analysis by Mechanisms of Action, 2023 (%)

Buy The Full Report for More Moa Insights Into AUD Marketed Drugs, Download A Free Report Sample

AUD Marketed Drugs Segmentation by Routes of Administration

The key routes of administration for AUD marketed drugs are oral, injection, and suppository. In 2023, most of the marketed drugs available for AUD are oral drugs.

AUD Marketed Drugs Analysis by Routes of Administration, 2023 (%)

Buy The Full Report for More RoA Insights Into AUD Marketed Drugs, Download A Free Report Sample

AUD Pipeline Drugs Market Segmentation by Mechanisms of Action

The key mechanisms of action for AUD pipeline drugs are receptor antagonist, receptor agonist, enzyme inhibitor, transporter inhibitor, ion channel inhibitor, protein and peptide activator, and receptor modulator. In 2023, most of the drugs in the AUD pipeline are receptor antagonists.

AUD Pipeline Drugs Market Analysis by Mechanisms of Action, 2023 (%)

Buy The Full Report for More Moa Insights Into AUD Pipeline Drugs, Download A Free Report Sample

AUD Pipeline Drugs Market Segmentation by Routes of Administration

The key routes of administration for AUD pipeline drugs are oral, injection, inhalational, and topical. In 2023, most of the drugs in the AUD pipeline are administered orally, followed by injections.

AUD Pipeline Drugs Market Analysis by Routes of Administration, 2023 (%)

Buy The Full Report for More RoA Insights Into AUD Pipeline Drugs, Download A Free Report Sample

AUD Pipeline Drugs Market Segmentation by Molecule Type

The key molecule types for the AUD pipeline drugs market are small molecule, biologic, and oligonucleotide. In 2023, the AUD pipeline is mostly made up of small molecules.

AUD Pipeline Drugs Market Analysis by Molecule Types, 2023 (%)

Buy The Full Report for More Molecule Types Insights Into AUD Pipeline Drugs, Download A Free Report Sample

Alcohol Use Disorder Competitive Analysis

Some of the top sponsors in the AUD marketed and pipeline drugs market are Yale University, Medical University of South Carolina, University of California San Francisco, Brown University, and National Institute on Alcohol Abuse and Alcoholism, among others. In 2023, Yale University leads among the sponsors for completed trials in AUD as well as in terms of ongoing trials.

AUD Marketed and Pipeline Drugs Market Analysis by Sponsors, 2023 (%)

Buy The Full Report for More Moa Insights Into AUD Drugs Companies, Download A Free Report Sample

Segments Covered in the Report

AUD Marketed Drugs Mechanism of Action (Number of Drugs, 2023)

• Receptor Agonists
• Receptor Antagonist
• Enzyme Inhibitor
• Ion Channel Blocker
• Transporter Inhibitor

AUD Marketed Drugs Routes of Administration Outlook (Number of Drugs, 2023)

• Oral
• Injection
• Suppository

AUD Pipeline Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)

• Receptor Antagonist
• Receptor Agonist
• Enzyme Inhibitor
• Transporter Inhibitor
• Ion Channel Inhibitor
• Protein and Peptide Activator
• Receptor Modulator

AUD Pipeline Drugs Routes of Administration Outlook (Number of Drugs, 2023)

• Oral
• Injection
• Inhalational
• Topical

AUD Pipeline Drugs Molecule Types Outlook (Number of Drugs, 2023)

• Small Molecule
• Biologic
• Oligonucleotide

Scope

GlobalData’s AUD: Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

Components of the report include –

• Disease Landscape
• Disease Overview
• Epidemiology Overview
• Treatment Overview
• Marketed Products Assessment
• Breakdown by Mechanism of Action, Molecule Type, Route of Administration
• Product Profiles with Sales Forecast
• Pricing and Reimbursement Assessment
• Annual Therapy Cost
• Time to Pricing and Time to Reimbursement
• Pipeline Assessment
• Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
• Product Profiles with Sales Forecast
• Late-to-mid-stage Pipeline Drugs
• Phase Transition Success Rate and Likelihood of Approval
• Clinical Trials Assessment
• Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
• Enrolment Analytics, Site Analytics, Feasibility Analysis
• Deals Landscape
• Mergers, Acquisitions, and Strategic Alliances by Region
• Overview of Recent Deals
• Commercial Assessment
• Key Market Players
• Future Market Catalysts

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the AUD market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global AUD market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.